Table 3

The indication and contraindication of thromboprophylaxis for patients with lung cancer

Pharmacologic thromboprophylaxisSurgical patients with lung cancer
Hospitalised medical patients receiving/starting systemic therapy for lung cancer
Patients with lung cancer with intermediate or high risk for VTE (Khorana score ≥2)
Active bleeding
Thrombocytopenia (platelet count <50 000/µL)
Underlying haemorrhagic coagulopathy or known bleeding disorder
Mechanical thromboprophylaxisThe abovementioned situations with (preferred) or without contraindication to anticoagulationAcute DVT (unless on therapeutic anticoagulation)
Severe arterial insufficiency
  • DVT, deep venous thrombosis; VTE, venous thromboembolism.